1. |
Bray F, Laversanne M, Sung H, et al. Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 2024, 74(3): 229-263.
|
2. |
WHO Classification of Tumours Editorial Board. WHO classification of tumours. Thoracic tumours. 5th ed. Lyon: IARC Press, 2021.
|
3. |
李媛, 谢惠康, 武春燕. WHO胸部肿瘤分类(第5版)中肺肿瘤部分解读. 中国癌症杂志, 2021, 31(7): 574-580.Li Y, Xie HK, Wu CY. Interpretation of lung tumours in the WHO classification of thoracic tumours (5th edition). China Oncol, 2021, 31(7): 574-580.
|
4. |
Tang ZM, Ling ZG, Wang CM, et al. Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis. PLoS One, 2017, 12(7): e0182117.
|
5. |
贾金芳, 黄静, 朱晓莉. 肿瘤相关自身抗体对恶性肺结节的诊断价值. 中国肿瘤临床, 2020, 47(6): 271-276.Jia JF, Huang J, Zhu XL. Diagnostic value of tumor-associated autoantibodies for malignant pulmonary nodules. Chin J Clin Oncol, 2020, 47(6): 271-276.
|
6. |
Zhang R, Ma L, Li W, et al. Diagnostic value of multiple tumor-associated autoantibodies in lung cancer. Onco Targets Ther, 2019, 12: 457-469.
|
7. |
Huang S, Yang J, Shen N, et al. Artificial intelligence in lung cancer diagnosis and prognosis: Current application and future perspective. Semin Cancer Biol, 2023, 89: 30-37.
|
8. |
Bidzińska J, Szurowska E. See lung cancer with an AI. Cancers (Basel), 2023, 15(4): 1321.
|
9. |
Imielinski M, Berger AH, Hammerman PS, et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell, 2012, 150(6): 1107-1120.
|
10. |
王璐, 刘杰克, 徐富阳, 等. 基于低剂量CT定量-定性特征预测低分化浸润性非黏液肺腺癌. 临床放射学杂志, 2023, 42(12): 1887-1894.Wang L, Liu JK, Xu FY, et al. Quantitative-semanticfeatures of low-dose CT for predicting the poorly differentiated invasive non-mucinous pulmonary adenocarcinoma. J Clin Radiol, 2023, 42(12): 1887-1894.
|
11. |
刘苗苗, 南岩东, 陈艳丽, 等. 血清肿瘤标志物和自身抗体与肺癌患者临床病理特征的相关性研究. 中华肺部疾病杂志(电子版), 2018, 11(2): 176-181.Liu MM, Nan YD, Chen YL, et al. Correlation of serum tumor markers and autoantibodies with clinicopathological features in lung cancer patients. Chin J Lung Dis (electronic edition), 2018, 11(2): 176-181.
|
12. |
Tan EM. Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J Clin Invest, 2001, 108(10): 1411-1415.
|
13. |
张东军, 刘丽伟, 刘洋, 等. 胸膜凹陷征在胸膜下磨玻璃结节诊断中的价值. 东南大学学报(医学版), 2020, 39(3): 297-300.Zhang DJ, Liu LW, Liu Y, et al. Value of pleural indentation in the diagnosis of subpleural ground glass nodules. J Southeast Univ (Med Sci Ed), 2020, 39(3): 297-300.
|
14. |
黄定品, 傅钢泽, 项益岚, 等. 纯磨玻璃肺小腺癌内异常空气支气管征与病理亚型的相关性. 医学影像学杂志, 2019, 29(12): 2047-2050.Huang DP, Fu GZ, Xiang YL, et al. Correlation between abnormal air bronchograms and pathological subtypes in small lung adenocarcinoma with pure ground glass nodule. J Med Imaging, 2019, 29(12): 2047-2050.
|
15. |
黄丽珍, 车建华, 段相会, 等. 非小细胞肺癌患者血清CYFRA21-1、VEGF及CEA的表达及与临床病理特征的相关性研究. 现代生物医学进展, 2018, 18(7): 1344-1347.Huang LZ, Che JH, Duan XH, et al. The expression of serum CYFRA21-1, VEGF and CEA in patients with non-small cell lung cancer and their correlation with clinicopathological features. Prog Mod Biomed, 2018, 18(7): 1344-1347.
|
16. |
金文霞, 李世良. 肺癌患者血清肿瘤标志物表达变化与临床病理特征的相关性分析. 实用癌症杂志, 2024, 39(2): 222-224,236.Jin WX, Li SL. Correlation analysis between changes in serum tumor markers expression and clinical pathological characteristics in lung cancer patients. Pract J Cancer, 2024, 39(2): 222-224,236.
|
17. |
翁绳和. 肺腺癌分化程度的相关因素分析. 中国医药科学, 2020, 10(4): 243-246.Weng SH. Analysis on related factors of differentiation degree of lung adenocarcinoma. China Med Pharm, 2020, 10(4): 243-246.
|
18. |
Lee KH, Goo JM, Park SJ, et al. Correlation between the size of the solid component on thin-section CT and the invasive component on pathology in small lung adenocarcinomas manifesting as ground-glass nodules. J Thorac Oncol, 2014, 9(1): 74-82.
|